<DOC>
	<DOCNO>NCT02865161</DOCNO>
	<brief_summary>This study conduct study efficacy safety Niselat patient osteoarthritis .</brief_summary>
	<brief_title>Amtolmetin Gaucil Knee Osteoarthritis</brief_title>
	<detailed_description>Osteoarthritis common rheumatic disease . Knee OA ( KOA ) , gonarthrosis ( GA ) , characterize high prevalence , progressive course early disability subject , persistent pain syndrome treatment non-steroidal anti inflammatory drug ( NSAIDs ) actively use clinical practice . It reveal NSAIDs may cause gastrointestinal adverse effect ( AEs ) , mild dyspepsia bleed perforation well cardiovascular effect . Gastroprotection misoprosol , Н2-receptor antagonist proton pump inhibitor ( PPI ) always effective . NSAIDs low gastrointestinal toxicity efficacy adequate suppress joint pain justify reasonable . Amtolmetin guacil ( AMG ) new NSAID prove least gastrointestinally toxic experimental study vivo , vitro comparative clinical study . AMG selectivity towards COX-2 NO . AMG exert gastroprotective effect due stimulation capsaicin receptor ( vanilloid receptor ) gastrointestinal wall . To assess tolerability amtolmetin guacil , first necessary obtain data potential reduction dyspeptic symptom include subject sign NSAIDs intolerability .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . Informed consent form participation study ; 2 . KOA ( base ACR , 1987 ) 3 . Age 3060 year old 4 . Previous regular administration NSAIDs least 4 week ( maximum therapeutic dose ) 5 . Dyspeptic symptom ( accord SODA questionnaire ) 6 . Pain intensity investigate knee joint ≥ 40 mm accord VAS 7 . Subjects systolic blood pressure ≤ 140 mm Hg diastolic BP ≤90 mmHg stable antihypertensive therapy . 1 . Contraindications amtolmetin guacil ( accord patient information leaflet ) 2 . Subjects SBP ≥140 mm Hg DBP ≥90 mm Hg 3 . Signs renal hepatic failure ; 4 . Pregnancy , lactation planning pregnancy . 5 . One follow change laboratory value screen HGB , WBC , ESR , ALT , AST .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>